8281 — Xebio Holdings Co Income Statement
0.000.00%
- ¥44bn
- ¥36bn
- ¥251bn
- 62
- 84
- 41
- 72
Annual income statement for Xebio Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 202,438 | 223,282 | 239,293 | 242,433 | 250,603 |
| Cost of Revenue | |||||
| Gross Profit | 78,820 | 87,054 | 91,774 | 92,887 | 97,672 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 202,306 | 220,037 | 231,377 | 239,119 | 248,015 |
| Operating Profit | 132 | 3,245 | 7,916 | 3,314 | 2,588 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3,095 | 6,214 | 8,836 | 4,521 | 3,077 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 414 | 3,853 | 5,595 | 2,732 | 979 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 413 | 3,836 | 5,399 | 2,593 | 971 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 412 | 3,836 | 5,397 | 2,592 | 971 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 40.8 | 119 | 138 | 77.2 | 89.5 |
| Dividends per Share |